Evaluation of the management of anemia in hemodialysis patients in Lebanon
Introduction: Chronic kidney disease (CKD) patients suffer anemia as one of the major complications. Optimal therapy involves the administration and response monitoring of erythropoiesis-stimulating agents and iron therapy. Objectives: The purpose was to assess the adherence of anemia management in...
Main Authors: | Marwan Akel, Kholoud Shamas, Fouad Sakr, Mariam Dabbous, Jihan Safwan, Michelle Cherfan, Mohamad Iskandarani |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2017-04-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | http://jnephropharmacology.com/PDF/npj-6-68.pdf |
Similar Items
-
Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM‐HD Study
by: Ko‐Lin Kuo, et al.
Published: (2018-08-01) -
Erythropoietin and iron for anemia in HIV-infected patients undergoing maintenance hemodialysis in China: a cross-sectional study
by: Lei Peng, et al.
Published: (2022-02-01) -
The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
by: Dae Woong Kang, et al.
Published: (2012-03-01) -
Effects of Carnitine Supplement on Dyslipidemia and Anemia in Hemodialysis Patients
by: Afsoon Emami Naini, et al.
Published: (2011-07-01) -
Darbepoetin Use for the Treatment of Anemia in Hemodialysis Patients in Saudi Arabia
by: Shaheen Faissal, et al.
Published: (2006-01-01)